Market Value1,341,135,648
Total Holdings60
File Date2024-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
RARE / Ultragenyx Pharmaceutical Inc.
ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock)
QURE / uniQure N.V.
RLMD / Relmada Therapeutics, Inc.
AGIO / Agios Pharmaceuticals, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
SWAV / Shockwave Medical, Inc.
ALPN / Alpine Immune Sciences, Inc.
TGTX / TG Therapeutics, Inc.
VKTX / Viking Therapeutics, Inc.
AFMD / Affimed N.V.
LYEL / Lyell Immunopharma, Inc.
MGNX / MacroGenics, Inc.
ATRA / Atara Biotherapeutics, Inc.
IMNM / Immunome, Inc.
SRPT / Sarepta Therapeutics, Inc.
DNTH / Dianthus Therapeutics, Inc.
SVRA / Savara Inc.
GERN / Geron Corporation
IMTX / Immatics N.V.
SLNO / Soleno Therapeutics, Inc.
ALLO / Allogene Therapeutics, Inc.
XENE / Xenon Pharmaceuticals Inc.
FULC / Fulcrum Therapeutics, Inc.
NRIX / Nurix Therapeutics, Inc.
ITOS / iTeos Therapeutics, Inc.
AXSM / Axsome Therapeutics, Inc.
BMY / Bristol-Myers Squibb Company
BNTX / BioNTech SE - Depositary Receipt (Common Stock)
APLS / Apellis Pharmaceuticals, Inc.
ACLX / Arcellx, Inc.
ANRO / Alto Neuroscience, Inc.
NARI / Inari Medical, Inc.
GLUE / Monte Rosa Therapeutics, Inc.
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
KRYS / Krystal Biotech, Inc.
NBIX / Neurocrine Biosciences, Inc.
INCY / Incyte Corporation
BIO / Bio-Rad Laboratories, Inc.
ATRA / Atara Biotherapeutics, Inc.
FATE / Fate Therapeutics, Inc.
LXEO / Lexeo Therapeutics, Inc.
LYRA / Lyra Therapeutics, Inc.
PRME / Prime Medicine, Inc.
INSP / Inspire Medical Systems, Inc.
INSM / Insmed Incorporated
ATXS / Astria Therapeutics, Inc.
VTYX / Ventyx Biosciences, Inc.
BGNE / BeiGene, Ltd. - Depositary Receipt (Common Stock)
ALXO / ALX Oncology Holdings Inc.
PCRX / Pacira BioSciences, Inc.
GMED / Globus Medical, Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
RPHM / Reneo Pharmaceuticals, Inc.
PRAX / Praxis Precision Medicines, Inc.
EXAS / Exact Sciences Corporation
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
SLDB / Solid Biosciences Inc.
NVAX / Novavax, Inc.
BDTX / Black Diamond Therapeutics, Inc.
JANX / Janux Therapeutics, Inc.
APLT / Applied Therapeutics, Inc.
BMRN / BioMarin Pharmaceutical Inc.
DAWN / Day One Biopharmaceuticals, Inc.
ZYME / Zymeworks Inc.
CMRX / Chimerix, Inc.
NAMS / NewAmsterdam Pharma Company N.V.
IOVA / Iovance Biotherapeutics, Inc.
PTCT / PTC Therapeutics, Inc.
LQDA / Liquidia Corporation
CYTK / Cytokinetics, Incorporated
PASG / Passage Bio, Inc.
VYGR / Voyager Therapeutics, Inc.
JAZZ / Jazz Pharmaceuticals plc
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
DYN / Dyne Therapeutics, Inc.
KALV / KalVista Pharmaceuticals, Inc.
VERV / Verve Therapeutics, Inc.
DNLI / Denali Therapeutics Inc.